TNDM SEC Filings: 8-K, 10-Q, S-3 & 424B

Financials

TYPE

HEADLINE

FILED AT

10-Q

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Nov 5, 2026

10-Q

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Aug 6, 2026

10-Q

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

May 7, 2026

10-K

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]

Feb 19, 2026

10-Q

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Nov 6, 2025

10-Q

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Aug 6, 2025

News

TYPE

HEADLINE

FILED AT

8-K

Tandem Diabetes Care Reports Third Quarter 2026 Financial Results and Reaffirms Full-Year Guidance

Nov 5, 2026

8-K

Tandem Diabetes Care Reports Second Quarter 2026 Financial Results

Aug 6, 2026

8-K

Tandem Diabetes Care Announces Results of 2026 Annual Meeting of Stockholders

May 21, 2026

8-K

Tandem Diabetes Care Announces Departure of Chief Commercial Officer

May 15, 2026

8-K

Tandem Diabetes Care Reports First Quarter 2026 Financial Results and Reaffirms Full-Year Guidance

May 7, 2026

8-K

Tandem Diabetes Care Announces Proposed Private Placement of Convertible Notes

Feb 27, 2026

Prospectus

TYPE

HEADLINE

FILED AT

424B5

3,508,770 Shares

Aug 3, 2018

424B5

Common Stock

Aug 2, 2018

424B4

30,000,000 Shares

Feb 9, 2018

424B5

4,630,000 Shares of Common Stock

Oct 13, 2017

424B5

Shares of Common Stock

Oct 12, 2017

424B5

Common Stock

Jul 27, 2017

Registrations

TYPE

HEADLINE

FILED AT

S-8

Form S-8 - Securities to be offered to employees in employee benefit plans

May 27, 2026

S-8

Registration

May 22, 2024

S-8

Registration

Aug 3, 2023

S-8

Common Stock

Aug 1, 2019

S-8

Common Stock

Aug 17, 2018

S-3MEF

Common Stock

Aug 3, 2018

Proxies

TYPE

HEADLINE

FILED AT

DEFA14A

Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material

Apr 7, 2026

DEF 14A

Form DEF 14A - Other definitive proxy statements

Apr 7, 2026

PRE 14A

Form PRE 14A - Other preliminary proxy statements

Mar 27, 2026

DEFA14A

Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material

Apr 8, 2025

DEF 14A

Form DEF 14A - Other definitive proxy statements

Apr 8, 2025

DEFA14A

Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material

Apr 9, 2024

Ownerships

TYPE

HEADLINE

FILED AT

SCHEDULE 13G

NEWGOLDMAN SACHS GROUP INC (Filed by)

Nov 9, 2026

TWOMEY CHRISTOPHER J (Reporting)

Oct 29, 2026

144

Form 144 - Report of proposed sale of securities

Oct 27, 2026

Kyrillos Jean-Claude (Reporting)

Oct 19, 2026

144

Form 144 - Report of proposed sale of securities

Sep 17, 2026

Vosseller Leigh (Reporting)

Aug 18, 2026

Other

TYPE

HEADLINE

FILED AT

Form SD - Specialized disclosure report

May 28, 2026

LETTER

Form UPLOAD - SEC-generated letter

Jun 26, 2025

CORRESP

Form CORRESP - Correspondence

Jun 25, 2025

LETTER

Form UPLOAD - SEC-generated letter

Jun 11, 2025

Form SD - Specialized disclosure report

May 29, 2025

CORRESP

Form CORRESP - Correspondence

May 23, 2025

Tandem Diabetes Care, Inc. TNDM · SEC Filings